Successful umbilical cord blood transplantation for severe chronic active Epstein-Barr virus infection after the double failure of hematopoietic stem cell transplantation

masataka ishimura, Shoichi Ohga, Akihiko Nomura, Taikai Toubo, Eiji Morihana, Yusuke Saito, Hisanori Nishio, Makoto Ide, Hidetoshi Takada, Toshiro Hara

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

An 11-year-old boy with severe chronic active Epstein-Barr virus infection (CAEBV) underwent successful cord blood transplantation (CBT) after consecutive failure of peripheral blood and bone marrow transplantation from his HLA-mismatched mother. CB cells from an unrelated donor were infused after conditioning with total body irradiation (12 Gy), melphalan (120 mg/m 2), and etoposide (600 mg/m2). Complete remission without circulating EBV-DNA has continued for 15 months after a delayed hematologic recovery. This is the first successful report of CBT for CAEBV. CB may therefore be an alternate source of stem cells for the curative treatment of CAEBV, despite the absence of EBV-specific cytotoxic T lymphocytes.

Original languageEnglish
Pages (from-to)207-212
Number of pages6
JournalAmerican Journal of Hematology
Volume80
Issue number3
DOIs
Publication statusPublished - Nov 1 2005

Fingerprint

Epstein-Barr Virus Infections
Hematopoietic Stem Cell Transplantation
Fetal Blood
Transplantation
Human Herpesvirus 4
Unrelated Donors
Melphalan
Whole-Body Irradiation
Cytotoxic T-Lymphocytes
Etoposide
Bone Marrow Transplantation
Stem Cells
Mothers
DNA
Therapeutics

All Science Journal Classification (ASJC) codes

  • Hematology

Cite this

Successful umbilical cord blood transplantation for severe chronic active Epstein-Barr virus infection after the double failure of hematopoietic stem cell transplantation. / ishimura, masataka; Ohga, Shoichi; Nomura, Akihiko; Toubo, Taikai; Morihana, Eiji; Saito, Yusuke; Nishio, Hisanori; Ide, Makoto; Takada, Hidetoshi; Hara, Toshiro.

In: American Journal of Hematology, Vol. 80, No. 3, 01.11.2005, p. 207-212.

Research output: Contribution to journalArticle

@article{f6ac836d39da4d7e9e5dfbdcd86c1086,
title = "Successful umbilical cord blood transplantation for severe chronic active Epstein-Barr virus infection after the double failure of hematopoietic stem cell transplantation",
abstract = "An 11-year-old boy with severe chronic active Epstein-Barr virus infection (CAEBV) underwent successful cord blood transplantation (CBT) after consecutive failure of peripheral blood and bone marrow transplantation from his HLA-mismatched mother. CB cells from an unrelated donor were infused after conditioning with total body irradiation (12 Gy), melphalan (120 mg/m 2), and etoposide (600 mg/m2). Complete remission without circulating EBV-DNA has continued for 15 months after a delayed hematologic recovery. This is the first successful report of CBT for CAEBV. CB may therefore be an alternate source of stem cells for the curative treatment of CAEBV, despite the absence of EBV-specific cytotoxic T lymphocytes.",
author = "masataka ishimura and Shoichi Ohga and Akihiko Nomura and Taikai Toubo and Eiji Morihana and Yusuke Saito and Hisanori Nishio and Makoto Ide and Hidetoshi Takada and Toshiro Hara",
year = "2005",
month = "11",
day = "1",
doi = "10.1002/ajh.20430",
language = "English",
volume = "80",
pages = "207--212",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Successful umbilical cord blood transplantation for severe chronic active Epstein-Barr virus infection after the double failure of hematopoietic stem cell transplantation

AU - ishimura, masataka

AU - Ohga, Shoichi

AU - Nomura, Akihiko

AU - Toubo, Taikai

AU - Morihana, Eiji

AU - Saito, Yusuke

AU - Nishio, Hisanori

AU - Ide, Makoto

AU - Takada, Hidetoshi

AU - Hara, Toshiro

PY - 2005/11/1

Y1 - 2005/11/1

N2 - An 11-year-old boy with severe chronic active Epstein-Barr virus infection (CAEBV) underwent successful cord blood transplantation (CBT) after consecutive failure of peripheral blood and bone marrow transplantation from his HLA-mismatched mother. CB cells from an unrelated donor were infused after conditioning with total body irradiation (12 Gy), melphalan (120 mg/m 2), and etoposide (600 mg/m2). Complete remission without circulating EBV-DNA has continued for 15 months after a delayed hematologic recovery. This is the first successful report of CBT for CAEBV. CB may therefore be an alternate source of stem cells for the curative treatment of CAEBV, despite the absence of EBV-specific cytotoxic T lymphocytes.

AB - An 11-year-old boy with severe chronic active Epstein-Barr virus infection (CAEBV) underwent successful cord blood transplantation (CBT) after consecutive failure of peripheral blood and bone marrow transplantation from his HLA-mismatched mother. CB cells from an unrelated donor were infused after conditioning with total body irradiation (12 Gy), melphalan (120 mg/m 2), and etoposide (600 mg/m2). Complete remission without circulating EBV-DNA has continued for 15 months after a delayed hematologic recovery. This is the first successful report of CBT for CAEBV. CB may therefore be an alternate source of stem cells for the curative treatment of CAEBV, despite the absence of EBV-specific cytotoxic T lymphocytes.

UR - http://www.scopus.com/inward/record.url?scp=27644478025&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27644478025&partnerID=8YFLogxK

U2 - 10.1002/ajh.20430

DO - 10.1002/ajh.20430

M3 - Article

VL - 80

SP - 207

EP - 212

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 3

ER -